+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae



Beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae



Journal of Antimicrobial ChemoTherapy 15 Suppl C: 111-117



By means of a micro-dilution technique (10(5) cfu/cup) 30 strains of Pseudomonas spp. were found resistant to Sch 34343. The susceptibility of Acinetobacter spp. (20 strains) was greatest for imipenem, followed by Sch 34343 (MIC approximately 0.7 mg/l), ceftazidime and ceftriaxone. Ten Moraxella strains were very susceptible to Sch 34343, imipenem and ceftazidime. For 35 strains of Neisseria gonorrhoeae (ten beta-lactamase-positive) and ten strains of N. meningitidis we noted no resistance to Sch 34343 (MIC 0.015-0.06 mg/l), or to any of the other drugs tested. Sixty-two strains of Enterobacteriaceae producing various beta-lactamases were tested for their sensitivity to Sch 34343 and seven other beta-lactams. To an even greater extent than imipenem and Sch 34343, latamoxef and ceftazidime proved very active against all these strains. A PSE-4-producing Escherichia coli strain was resistant to Sch 34343. The inoculum effect (10(6) vs 10(4) cfu/ml) on Sch 34343 activity was usually small (1-4). Tests for the beta-lactamase susceptibility of Sch 34343 showed that only one PSE-3, one PSE-4 and one chromosomal beta-lactamase from a strain of Enterobacter cloacae were slightly active.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041996468

Download citation: RISBibTeXText

PMID: 3928576


Related references

-Lactamase susceptibility and comparative activity of Sch 34343 and other Mactams for non-fermenters, Neisseria spp. and Mactamase-positive Enterobacteriaceae. Journal of Antimicrobial ChemoTherapy 15(Suppl C): 111-117, 1985

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes. Antimicrobial Agents and ChemoTherapy 30(5): 789-791, 1986

In vitro activity of rosamicin josamycin erythromycin and clindamycin against beta lactamase negative and beta lactamase positive strains of neisseria gonorrhoeae. Antimicrobial Agents & Chemotherapy 15(2): 243-245, 1979

Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase. Journal of Pharmacy and Pharmacology 55(6): 735-740, 2003

Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants. Drugs Under Experimental and Clinical Research 12(4): 329-333, 1986

Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates. Journal of the College of Physicians and Surgeons--Pakistan 22(6): 358-362, 2012

Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations. Journal of Antimicrobial ChemoTherapy 32(3): 431-444, 1993

Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams. Diagnostic Microbiology and Infectious Disease 53(2): 131-141, 2005

Effect of different beta-lactams in combination with beta-lactamase inhibitors in the presence or absence of tobramycin against some enterobacteriaceae producing extended-spectrum beta-lactamases. ChemoTherapy 44(5): 313-317, 1998

Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase. Journal of Antimicrobial ChemoTherapy 53(2): 297-304, 2004

Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against beta-lactamase inducible Pseudomonas aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 12, 2002

Beta lactamase of mycobacteria and the in vitro synergistic activities of various beta lactams combined with the beta lactamase inhibitor ytr 830h. Abstracts of the General Meeting of the American Society for Microbiology 92: 181, 1992

OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors. Biochimica et Biophysica Acta 1432(1): 125-136, 1999

OHIO-1 beta-lactamase mutants The Arg244Ser mutation and resistance to beta-lactams and beta-lactamase inhibitors. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 82, 1997

Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis. International Journal of Antimicrobial Agents 52(5): 554-570, 2018